Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia
Clinical trial NCT05227820 · COMPLETED
Trial details
- NCT number
- NCT05227820
- Sponsor
- Neurological Associates of West Los Angeles
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2022-07-20
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.